Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne medication for the treatment of acne

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne medication for the treatment of acne

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

harris pharmaceutical, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne medication - for the treatment of acne

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

geritrex llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - for the treatment of acne

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

malezia llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) -

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

kmm pharmaceuticals, llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - acne treatment for the treatment of acne

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

bryant ranch prepack - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm), clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. [see postmarketing experience (6.2). ] clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. [see warnings and precautions (5.1). ] risk summary there are no available data on clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcome

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

malezia llc - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) -

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

viona pharmaceuticals inc - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - adapalene and benzoyl peroxide topical gel is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. adapalene and benzoyl peroxide topical gel is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in adapalene and benzoyl peroxide topical gel. risk summary available pharmacovigilance data with adapalene and benzoyl peroxide topical gel use in pregnant women are insufficient to establish a drug associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with the combination gel. adapalene gel, 0.3% available data from clinical trials with adapalene gel 0.3% use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. in animal reproduction studies, oral administration of adapalene to pregnant r

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - benzoyl peroxide - cutaneous gel - 50mg/1gram